科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

科华智慧（深圳）创新药物研发有限公司海根生物(深圳)有限公司联合开发

中文 EN

主页

产品

天然产物数据库

技术服务

科技资讯

公司介绍

联系方式

中文 EN

植物来源

结构类型

微生物来源

大品种

合成化合物

-合成化合物

CAS No.	英文名/中文名/SMILES	分子式	分子量	含量	价格	二维结构图
1362850-20-1	Seletalisib Seletalisib	C₂₃H₁₄ClF₃N₆O	482.8	99%	点击查询
13650-70-9	tert-Butyl (S)-(-)-lactate tert-Butyl L-lactate	C₇H₁₄O₃	146.18	98%	点击查询
1365267-27-1	(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide Ensartinib	C₂₅H₂₅Cl₂FN₆O₃	547.4	98%	点击查询
1365267-35-1	Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-	C₂₉H₃₂N₆O₉	608.6	98%	点击查询
1365267-36-2	1,2-Benzenedicarboxamide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- Rivaroxaban Impurity IV (Potential Impurity)	C₃₆H₃₆N₆O₁₀	712.7	98%	点击查询
1365267-37-3	Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]carbonyl]- Rivaroxaban Impurity V (Potential Impurity)	C₂₂H₂₁N₃O₇	439.4	98%	点击查询
136558-13-9	Ethyl 5-(tert-butylthio)-2,2-dimethyl-4-oxopentanoate Ethyl 5-tert-Butylthio-2,2-dimethyl-4-oxopentanoate	C₁₃H₂₄O₃S	260.39	98%	点击查询
1365888-06-7	Brilanestrant GDC-0810	C₂₆H₂₀ClFN₂O₂	446.9	99%	点击查询
1365920-11-1	PropanaMide,N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]- Propanamide, N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]-	C₁₆H₁₉NO₂	257.33	98%	点击查询
136668-42-3	Quiflapon MK-0591	C₃₄H₃₅ClN₂O₃S	587.2	95%	点击查询

C₂₃H₁₄ClF₃N₆O 482.8

tert-Butyl (S)-(-)-lactate

tert-Butyl L-lactate

C₇H₁₄O₃ 146.18

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide

C₂₅H₂₅Cl₂FN₆O₃ 547.4

Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

C₂₉H₃₂N₆O₉ 608.6

1,2-Benzenedicarboxamide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

Rivaroxaban Impurity IV (Potential Impurity)

C₃₆H₃₆N₆O₁₀ 712.7

Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]carbonyl]-

Rivaroxaban Impurity V (Potential Impurity)

C₂₂H₂₁N₃O₇ 439.4

Ethyl 5-(tert-butylthio)-2,2-dimethyl-4-oxopentanoate

Ethyl 5-tert-Butylthio-2,2-dimethyl-4-oxopentanoate

C₁₃H₂₄O₃S 260.39

C₂₆H₂₀ClFN₂O₂ 446.9

PropanaMide,N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]-

Propanamide, N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]-

C₁₆H₁₉NO₂ 257.33

C₃₄H₃₅ClN₂O₃S 587.2

<上一页 1 2 3 4 5 6 7 8 9 10 ... (当前15218页) 16106 下一页>

本公司所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

公司地址:深圳市南山区粤海街道高新区社区粤兴二道1号虚拟大学园重点实验室平台大楼B410

电话:400-856-5689

邮箱:kehuaai@kehuaai.com

科华智慧（深圳）创新药物研发有限公司

备案号：粤ICP备2024241782号